Daniel Rubin

Dan became President and CEO at PARx in mid-2012. In his role, Dan is responsible for helping to set the company’s strategic direction while working closely with key clients and strategic partners.

Prior to joining PARx, Dan served as the co-founder and CEO of Adheris, Inc. from the company’s inception in 1993 until 2008 when he became the President of inVentiv Health’s Patient Outcomes division. As President of inVentiv Patient Outcomes, Dan oversaw multiple businesses including Adheres; The Franklin Group, a business that provides patient assistance and reimbursement case management programs to the pharmaceutical industry; in addition to several other businesses providing prescription-related services.